Westmecklenburg Klinikum Helene von Buelow GmbH
- Address
- lock Available on a paid plan
Diseases and Pain Disorders
At Westmecklenburg Klinikum Helene von Buelow GmbH, the Center for Pain and Back Therapy is focused on pathological conditions, signs and symptoms related to persistent pain. The clinical trials in this area center on understanding and improving care for people living with long-lasting pain conditions.
- Chronic pain due to diabetic polyneuropathy
- Chronic pain from traumatic or post-operative peripheral neuropathy
- Chronic pain linked to central neuropathy
- Chronic back pain
These studies are designed to evaluate a new add-on treatment and to better understand its potential to relieve pain and improve daily functioning for patients with difficult-to-treat nerve and back pain.
Neuropathic Pain Research
The site is also conducting research into neuropathic pain, with a particular emphasis on pain caused by nerve damage or dysfunction. This work aims to test whether a new therapy can provide meaningful symptom relief in people affected by different forms of nerve-related pain.
- Diabetic nerve pain
- Peripheral nerve pain after trauma or surgery
- Central nerve pain of varied origin
By studying several related conditions, the trials explore whether treatment benefits extend across multiple neuropathic pain types rather than only one diagnosis.
Back Pain Treatment Studies
Research at this hospital in Hagenow includes trials for chronic back pain, a major cause of ongoing discomfort and reduced quality of life. The studies are focused on assessing treatment effectiveness and tolerability in routine clinical care settings.
- Long-term back pain management
- Symptom relief and improved function
- Evaluation of a supportive add-on therapy
This area of research reflects a broader effort to improve treatment options for patients with persistent musculoskeletal pain.
Pain Management Clinical Research
The overall trial portfolio is small but highly focused, with studies examining whether a new supportive treatment can help patients with chronic pain from different causes. The research combines pain medicine and neurology to address both nerve-related and back-related pain conditions.
- Testing a new add-on therapy for persistent pain
- Improving symptom control across multiple pain conditions
- Supporting better treatment choices for patients and clinicians
With a single investigator and four trials, the Center for Pain and Back Therapy is building practical evidence to support more effective care for people living with chronic pain.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 1 therapeutic areas and 15 of 25 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Apurano Pharmaceuticals GmbH4trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Westmecklenburg Klinikum Helene von Buelow GmbH
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain | Apurano Pharmaceuticals GmbH | Phase III | Not Recruiting | Nov 2023 | Mar 2026 |
IMP list
lock Showing 1 of 25 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Adezunap | 4 | Unknown | 2023-11-02 | 2023-11-02 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
